RIL
XBI icon

Rothschild Investment LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Rothschild Investment LLC’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Sell
8,382
-142
-2% -$19.2K 0.05% 348
2026
Q1 		$1.09M Sell
8,524
-90
-1% -$11.2K 0.06% 260
2025
Q4 		$1.05M Buy
8,614
+2
+0% +$229 0.06% 245
2025
Q3 		$863K Sell
8,612
-87
-1% -$7.84K 0.05% 253
2025
Q2 		$721K Sell
8,699
-1,072
-11% -$85.5K 0.05% 264
2025
Q1 		$792K Buy
9,771
+116
+1% +$10.4K 0.05% 259
2024
Q4 		$870K Buy
9,655
+282
+3% +$27.3K 0.06% 257
2024
Q3 		$926K Buy
9,373
+4,595
+96% +$451K 0.06% 247
2024
Q2 		$443K Buy
4,778
+3,347
+234% +$300K 0.03% 353
2024
Q1 		$136K Buy
+1,431
New +$133K 0.01% 541
2017
Q2 		– Sell
-21,000
Closed -$1.46M – 485
2017
Q1 		$1.46M Buy
+21,000
New +$1.41M 0.17% 158

Other funds holding XBI

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.86B AUM 22.16% 1-Year Est. Return
G
GenTrust Miami, Florida $2.6B AUM 18.42% 1-Year Est. Return

Rothschild Investment LLC's XBI Position: Q2 2026 in Review

Rothschild Investment LLC reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 1.7% in Q2 2026, selling an estimated $19.2K and leaving 8,382 shares worth $1.33M. The position accounts for 0.05% of the portfolio, ranked #348.

Rothschild Investment LLC first reported a position in XBI in Q1 2017 and has held it in 11 quarters since. The position peaked at $1.46M in Q1 2017. 519 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Rothschild Investment LLC held 8,382 shares of State Street SPDR S&P Biotech ETF worth $1.33M as of Q2 2026.
  • Rothschild Investment LLC sold 142 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $19.2K.
  • State Street SPDR S&P Biotech ETF made up 0.05% of Rothschild Investment LLC's portfolio in Q2 2026, its #348 holding.
  • Rothschild Investment LLC first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and has held it in 11 quarters since.
  • Rothschild Investment LLC's State Street SPDR S&P Biotech ETF position peaked at $1.46M in Q1 2017.
  • 519 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.